Recellularization is scaling to larger tissue formats, bioreactor development is moving forward, and our community submitted 139 questions for an upcoming Q&A with our chief bioengineer. Read the full update: www.foregen.org/commentarium-articles/april-1st-2026

Your Questions for Foregen's Chief Bioengineer This May, we're heading to Slovakia to sit down with Ján Kováč, Foregen's Chief Bioengineer, for a special recorded Q&A session. This is your chance to ask Ján anything about the science behind foresk...

We're giving you the chance to ask Foregen's Chief Bioengineer Ján Kováč anything about the science behind foreskin regeneration. Submit your question and it could be featured in an upcoming Q&A video. forms.gle/TWyLe3zjfVP3...

Foregen: Scaling Up Recellularization, Unprecedented Biomechanics Data, and In Vivo Safety Testing - Larger samples, rigorous testing, and long-term safety data from our labs in Slovakia and Austria. Foregen's March 2026 newsletter: recellularization scales to larger samples, biomechanical testing completed in Graz, and in vivo safety studies progress toward publication.

Our March newsletter is live! From pilot recellularization to full-scale testing, biomechanical analysis in Austria, and ongoing in vivo safety studies, our research team in Slovakia continues to make progress toward clinical trials. Read the full update: www.foregen.org/commentarium...

Foregen: A Year in Review: 2025 - Substantial Research Progress and Fundraising Success Foregen’s 2025 Year in Review highlights major scientific and community milestones, including the launch of our new preclinical research collaboration with Dr. Stanislav Žiaran in Bratislava, a May si...

2025 pushed Foregen forward in a big way: real progress in the lab, new peer-reviewed science, and a community that showed up when it mattered most. If you want the clearest picture yet of what we accomplished and what’s coming next, read our Year in Review. www.foregen.org/commentarium...

This is a message we wish no one had to write.

Check out our latest newsletter, where we discuss our successful pilot recellularization test and our latest lab tour video! www.foregen.org/commentarium...

Foregen: Pilot Recellularization Results - Confirming scaffold viability and cell growth Foregen achieves successful pilot recellularization across 50 samples. Fibroblasts and stem cells verified on scaffolds via confocal microscopy.

Pilot recellularization success!

We’ve verified the attachment and proliferation of fibroblasts, keratinocytes, and stem cells across 50+ samples using confocal microscopy. 🔬

This proves our scaffolds are non-toxic and ready for new cells.

Read more: www.foregen.org/commentarium...

Foregen: January 4th, 2026 - $62,959 Raised: A Fundraising Win for the New Year! Foregen raises $62,959 to fund bioreactor scaling, prepares to complete Milestone 3, and moves toward the final preclinical phase: Milestone 4

HUGE NEWS: We raised $62,959 for our December match campaign! 🎉

We’re automating our bioreactors to build the "bioreactor farm" model. Plus, we’re wrapping Milestone 3 and moving to Milestone 4—the FINAL preclinical stage!

Read more: www.foregen.org/commentarium-articles/january-4th-2026

Foregen: December Matching Campaign Success! - We crushed our goal! Thank you for raising nearly $60k with the match. Foregen surpasses its $25k goal, raising $34,748 to fund bioreactor automation. Learn how this success accelerates our

Our community raised an incredible $34,748 for our December match campaign—nearly $10k over our target!

With the match, almost $60,000 is now fueling the automation of our bioreactors. This is the foundation for our "bioreactor farm" and clinical scaling.

www.foregen.org/commentarium...

We have officially reached 80% of our matching campaign goal! We only have 20% left to go—help us cross the finish line today.

Remember: every dollar you give is DOUBLED!

www.foregen.org/donate

We're halfway through the month! So far, we've raised $15,616, which is 62% of our overall goal. We are so grateful for the support you've given so far. Make a donation today and you can double your impact! www.foregen.org/donate

Q4 2025 Conference Call with Founder, CSO, and COO YouTube video by Foregen

Check out our latest Conference Call for an update on our research progress and an informative Q&A with donors! youtu.be/_rhCA1kbMXY

We've launched a $25K MATCHING CAMPAIGN to support the development of our bioreactor! Through the end of the year, each donation you make to Foregen will be matched, dollar-for-dollar. Check out our latest newsletter for more! www.foregen.org/commentarium...

Foregen: November 1st, 2025 - Rat trial results are published! Plus: Final safety testing is nearing completion in the lab Foregen hits major milestones in pre-clinical research: Dr. Palumbo's rat trial results are published, and decellularization is confirmed successful on all 20 samples.

Check out this month's newsletter for updates on the recent publication of an animal trials article, progress on our pre-clinical research project, and our latest YouTube video! www.foregen.org/commentarium...

Foregen Inside the Lab: Episode Two YouTube video by Foregen

Inside the Lab: Episode Two is out! Join us as we explore our partner's bioreactor technology and unique approaches to regenerative medicine. youtu.be/7WtN8HYsXbk

Foregen: New Article in Major Journal Highlights Flaws in American Circumcision Policy - The need for transparency on non-medical factors in circumcision policy. Foregen supports new JME article by Max Buckler arguing major medical bodies (AAP) influence circumcision policies with cultural and non-medical biases, violating non-maleficence. Demand transparency ...

An upcoming article on infant circumcision policy is soon to be published in the Journal of Medical Ethics. The central argument powerfully aligns with Foregen's ethics and marks an important moment in the shifting dynamics of the infant circumcision debate. www.foregen.org/commentarium...

The profound sense of loss for circumcised men is real. Foregen is building the scientific solution for men seeking to reclaim their complete body through advanced regenerative medicine. Learn more: www.foregen.org/commentarium...

It's not just about the research, it's about the dedication. The efforts of our team, including Ph.D. student and bioengineer Ján Kovác, have laid a strong foundation for our progress. Learn more in our latest post! www.foregen.org/commentarium...

New Foregen Newsletter is OUT! Get the latest on our pre-clinical research: Biocompatibility results are promising, key protocol refinements, and strong financial support from our dedicated community.

www.foregen.org/commentarium...

The sensory penis: A comprehensive immunohistological and ontogenetic exploration of human penile innervation Background Penile sexual sensation relies on intricate neural structures that remain incompletely characterized. Immunohistological insights into their development and organization can enhance under...

"The frenular delta, which is part of the ventral prepuce, along with the rest of the [foreskin] and the glans, are the primary erogenous zones of the penis, containing dense neural structures essential for the perception of sexual pleasure."

onlinelibrary.wiley.com/doi/10.1111/...

18.3 Million Reasons to Strive: www.foregen.org/commentarium...

Final milestone ahead. Lab tour video. Strong fundraising. Read more in our latest newsletter 👉 www.foregen.org/commentarium...

Foregen Inside the Lab: Episode One YouTube video by Foregen

Régénération du prépuce : @foregen.org lance une série de vidéos pour présenter ses recherches 🔬

Épisode 1 ▶️ www.youtube.com/watch?v=VZ3C... (24 août 2025)

#RégénérationDuPrépuce #prépuce #circoncision

Foregen Inside the Lab: Episode One YouTube video by Foregen

Check out our latest video! Go behind the scenes with Foregen's Chief Bioengineer, Ján Kováč, for an exclusive look at our partner research lab in Slovakia. youtu.be/VZ3C9eLN2Fg

Follow us and find out!

Foregen’s white paper is now live!

This document outlines the urgent need for foreskin restoration, the science behind our regenerative medicine approach, and our roadmap to human clinical trials.

Read it here: www.foregen.org/white-paper

Circumcision can leave lasting emotional and physical scars.
That's why we're developing a regenerative solution—because no one's pain should be ignored.

Our latest newsletter is out! Get the full story on our preclinical progress, the $52,167 we raised last month, and upcoming lab videos: www.foregen.org/commentarium...

Amazing news! Our July $25,000 matching campaign exceeded its goal! We raised $27,167, for a total impact of $52,167 with the match. This is YOUR success! Deepest gratitude to our incredible community. www.foregen.org/commentarium...

Our July $25K matching campaign is now at $24,684! Just $316 left to unlock the full match. Help us cross the finish line by July 31st! Donate now: www.foregen.org/donate